Q1 2025 Holdings
Filed 2025-05-15 | 38 holdings | $395.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $78.4M | 94,887 | 19.8% |
| ELI Lilly & Co(LLY)Put | COM | 532457108 | $37.2M | 45,000 | 9.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $35.6M | 498,473 | 9.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $34.2M | 538,488 | 8.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $29.0M | 219,719 | 7.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $24.3M | 318,239 | 6.1% |
| Merus N V | COM | N5749R100 | $17.9M | 424,640 | 4.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $16.1M | 333,851 | 4.1% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $15.0M | 229,085 | 3.8% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $14.0M | 190,752 | 3.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $13.1M | 129,700 | 3.3% |
| Soleno Therapeutics Inc(SLNO)Put | COM | 834203309 | $9.8M | 136,900 | 2.5% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $9.6M | 56,717 | 2.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $7.7M | 28,600 | 2.0% |
| Soleno Therapeutics Inc(SLNO)Call | COM | 834203309 | $7.1M | 100,000 | 1.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $6.7M | 11,311 | 1.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $6.4M | 90,745 | 1.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $5.5M | 172,185 | 1.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $3.7M | 104,190 | 0.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.6M | 50,000 | 0.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $2.4M | 53,930 | 0.6% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.2M | 90,279 | 0.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.2M | 160,000 | 0.5% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $2.1M | 54,515 | 0.5% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $1.7M | 3,500 | 0.4% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $1.7M | 316,700 | 0.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $1.6M | 14,700 | 0.4% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $1.5M | 5,000 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.3M | 40,000 | 0.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.2M | 7,440 | 0.3% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $1.0M | 38,100 | 0.3% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $948.1K | 421,359 | 0.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $553.7K | 30,900 | 0.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $506.6K | 35,226 | 0.1% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $75.7K | 7,380 | 0.0% |